| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/17/2009 | EP2070922A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070908A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
| 06/17/2009 | EP2070549A1 Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 06/17/2009 | EP2070544A2 Means of withdrawal from smoking |
| 06/17/2009 | EP2070526A1 "Methods for treatment of Parkinson's disease" |
| 06/17/2009 | EP2070519A1 Preparation for the prevention and/or treatment of dementia syndromes |
| 06/17/2009 | EP2069365A1 Novel 5,7-disubstituted [1, 3]thiazolo [4, 5d]pyrimidin-2 (3h)-amine derivatives and their use in therapy |
| 06/17/2009 | EP2069364A1 Novel 5, 7-disubstituted [1, 3]thiazolo [4, 5-d]pyrimidin-2 (3h)-one derivatives and their use in therapy |
| 06/17/2009 | EP2069346A1 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof |
| 06/17/2009 | EP2069342A1 2-aryl-6-phenylimidazo[1,2-alpha]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 06/17/2009 | EP2069334A1 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation |
| 06/17/2009 | EP2069332A2 Azetidine compounds as orexin receptor antagonists |
| 06/17/2009 | EP2069328A2 4-arylalkoxymethyl-4-phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders |
| 06/17/2009 | EP2069321A1 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof |
| 06/17/2009 | EP2069319A1 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers |
| 06/17/2009 | EP2069317A2 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| 06/17/2009 | EP2069316A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 06/17/2009 | EP2069315A2 Quinazolinone and isoquinolinone acetamide derivatives |
| 06/17/2009 | EP2069312A2 Pyridizinone derivatives |
| 06/17/2009 | EP2069310A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 06/17/2009 | EP2069302A1 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 06/17/2009 | EP2069300A2 Multimediator transporter inhibitors for use in treatment of central nervous system disorders |
| 06/17/2009 | EP2069021A2 Methods for treating at least one condition having mt1 receptor, 5ht2b receptor, and l-type calcium channel activity |
| 06/17/2009 | EP2068933A2 Pharmaceutical compositions of clonazepam and methods of use thereof |
| 06/17/2009 | EP2068887A2 Sp35 antibodies and uses thereof |
| 06/17/2009 | EP2068872A1 Combinations containing a 4-acylaminopyridine derivative |
| 06/17/2009 | EP2068870A2 Thiophene compounds |
| 06/17/2009 | EP2068863A2 Ligustilide derivatives for the treatment of disorders of the central nervous system |
| 06/17/2009 | EP2068840A2 Hydrophobic abuse deterrent delivery system |
| 06/17/2009 | EP2068630A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 06/17/2009 | EP2011497A4 Agent exhibiting a neurotropic, neuromodulator, cerebrovascular and anti- stroke activity |
| 06/17/2009 | EP1866306B1 Imidazopyridine derivatives useful as inos inhibitors |
| 06/17/2009 | EP1789410B1 Methylene dipiperidine derivatives |
| 06/17/2009 | EP1740591B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 06/17/2009 | EP1649862A4 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 06/17/2009 | EP1608653B1 SUBSTITUTED 8-PERFLUOROALKYL-6,7,8,9-TETRAHYDROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES |
| 06/17/2009 | EP1499616B1 Heterocyclic compounds |
| 06/17/2009 | EP1491204B1 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | EP1435957B1 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 06/17/2009 | EP1390378B1 Pharmaceutically active uridine esters |
| 06/17/2009 | EP1337518B1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 06/17/2009 | EP1322592B2 Substituted 1-aminobutan-3-ol derivatives |
| 06/17/2009 | EP0975595B1 Analogs of cocaine |
| 06/17/2009 | CN101460222A Thioninium compounds and their use |
| 06/17/2009 | CN100500662C Alkyl ether derivatives or salts thereof |
| 06/17/2009 | CN100500644C Interconnected medicine precursor of gabapentin and pregabalin and its medicinal use |
| 06/17/2009 | CN100500148C A buffered, liquid nicotine composition for pulmonary administration |
| 06/17/2009 | CN100500147C New formulations and use thereof |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547788 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |
| 06/16/2009 | US7547725 Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 06/16/2009 | US7547707 Spirocyclic cyclohexane compounds |
| 06/16/2009 | US7547705 Ethyl-1'-[(2S)-2-hydroxy-2-phenylethyl]-6'-oxo-8'-(pyridin-4-yl)-1',3',4',6'-tetrahydro-1H-spiro[piperidine-4,2'-pyrimido[1,2-a]pyrimidine]-1-carbox; glycogen synthase kinase-3 beta, amyloid precursor protein, tau protein hyperphosphorylation inhibitor; neurodegenerative disease, type II diabetes |
| 06/16/2009 | US7547700 Such as (3-chloro-4-fluorophenyl)(4-fluoro-4-{[(5-hydoxypyridin-2-ylmethyl)amino]methyl}piperidin-1-yl)methanone; serotonin receptor agonists; for treating depression, pain, and substance abuse |
| 06/16/2009 | US7547693 Piperidine derivative |
| 06/16/2009 | US7547532 Three-dimensional structure of prostaglandin D synthase and utilization thereof |
| 06/16/2009 | CA2487365C Piperidine derivatives as potassium channel blockers |
| 06/16/2009 | CA2444818C Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/16/2009 | CA2284802C Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 06/16/2009 | CA2278201C Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation |
| 06/16/2009 | CA2264750C Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
| 06/16/2009 | CA2202032C Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/12/2009 | CA2646208A1 Bone marrow-derived neuronal cells |
| 06/11/2009 | WO2009073779A1 Gamma secretase modulators |
| 06/11/2009 | WO2009073777A1 Gamma secretase modulators |
| 06/11/2009 | WO2009073725A2 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 06/11/2009 | WO2009073146A2 Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders |
| 06/11/2009 | WO2009072649A1 4-arylphenyl derivative |
| 06/11/2009 | WO2009072527A1 Composition for autotransplantation or allotransplantation using dental pulp stem cell, and use of the composition |
| 06/11/2009 | WO2009072086A1 Methods of and combination therapies for treating or delaying the onset of dyskinesia |
| 06/11/2009 | WO2009071988A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 06/11/2009 | WO2009071947A2 Potassium ion channel modulators and uses thereof |
| 06/11/2009 | WO2009071753A1 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 06/11/2009 | WO2009071732A1 Np1 activity regulating elements which can be used in the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof |
| 06/11/2009 | WO2009071725A2 Use of valproate for the treatment of fear and phobia in subjects with alzheimer's disease |
| 06/11/2009 | WO2009071689A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | WO2009071687A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | WO2009071657A1 Tricyclic triazolic compounds |
| 06/11/2009 | WO2009071577A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 06/11/2009 | WO2009071576A1 5-aryl-1,3,4-oxadiazole-2-amines as nicotinic acetylcholine receptor agonists |
| 06/11/2009 | WO2009071519A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 06/11/2009 | WO2009071477A1 Isoxazolo-pyridazine derivatives |
| 06/11/2009 | WO2009071476A1 Isoxazolo-pyridine derivatives |
| 06/11/2009 | WO2009071464A1 Isoxazolo-pyrazine derivatives |
| 06/11/2009 | WO2009071310A1 Crystalline modifications of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl -propyl)-phenol |
| 06/11/2009 | WO2009071277A1 Novel nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof |
| 06/11/2009 | WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof |
| 06/11/2009 | WO2009070924A1 Pharmaceutical compositions with a mechanism of multi-target receptor retroaction for treating depression |
| 06/11/2009 | WO2009070923A1 A pharmaceutical composition for treating melancholy and preparation method thereof |
| 06/11/2009 | WO2009070922A1 Pharmaceutical compositions for treating anxiety |
| 06/11/2009 | WO2009070921A1 Antimelancholic medicine prepared with jujube camp materials |